除了生物制剂的瓶颈

Novel biologics provide the opportunity to treat a wide range of medical conditions, but they require fresh manufacturing approaches to ensure drug integrity and sterility.

Single-use technology is undoubtedly the perfect partner for the biologics market, offering a complete fluid pathway.

Jim Sanford, Strategic Sector Manager, Life Sciences, provides his insights on the challenges that remain and how the industry can work together to overcome them for Chemistry and Industry (C&I).

Source: Chemistry and Industry (C&I).

Download: avoiding biologic bottlenecks